関連する実験動画
Updated: Jan 30, 2026

07:51
Pull-down of Calmodulin-binding Proteins
Published on: January 23, 2012
25.9K
ニューロブラストーマ幹細胞におけるサリノマイシンのための機能的結合タンパク質である
Fengfei Wang1,2,3,4, Shuang Zhou1,2,5, Dan Qi1,2
1Department of Neurosurgery , Baylor Scott & White Health , Temple , Texas 78508 , United States.
Journal of the American Chemical Society
|January 29, 2019
まとめ
この研究では,ニューロブラストーマ (NB) がん幹細胞 (CSC) の活動に不可欠なサリノマイシン標的として,ヌクレオリン (NCL) を特定しました. NCLを標的とした治療は,新しい治療戦略とNB患者の予後マーカーを提供することができる.
科学分野:
- 腫瘍学
- 分子生物学
- 薬理学について
背景:
- 神経芽細胞腫 (NB) は小児がんであり,有効な治療法に対する需要は大きく満たされていない.
- 抗がん幹細胞 (CSCs) は腫瘍の再発と治療抵抗に関与しています.
- サリノマイシンはCSC標的化剤として有望ですが,その正確な分子標的はほとんど定義されていません.
研究 の 目的:
- 神経芽細胞がん幹細胞 (CSCs) でのサリノマイシンの機能的結合標的を特定する.
- CSCの活動と治療反応の調節におけるこの標的の役割を解明する.
- 神経芽細胞腫の予後バイオマーカーとしてのこの標的の可能性を評価する.
主な方法:
- 統合された分子生物学戦略が採用された.
- 生物化学および細胞測定を用いたサリノマイシン結合標的の特定
- ニューロブラストーマ (NB) コホートにおけるヌクレオリン (NCL) 発現と患者の生存率との相関の分析.
- NCLがCD34発現とNBCSC活性を調節する役割を調査する.
主要な成果:
- ニュクレオリン (NCL) は,サリノマイシンの機能的結合標的として識別された.
- サリノミシンはNB CD34発現を抑制し,NCLに依存した方法でCD34+ CSCを減少させます.
- NCLはNCLとCD34プロモーターの相互作用を調節し,CSCの活動に影響を与えます.
- NB腫瘍におけるNCL発現の上昇は,患者の生存率の低下と相関する.
結論:
- ニュクレオリン (NCL) は,神経芽細胞腫 (NB) CSCの調節に重要な新しい機能的サリノマイシン結合標的である.
- NCLは,NB治療の潜在的な予後マーカーです.
- NCL-サリノマイシン相互作用をターゲットにすることで,神経芽細胞腫の新たな治療法が提供される可能性があります.
関連する概念動画
Mechanical Protein Functions
5.6K
Proteins perform many mechanical functions in a cell. These proteins can be classified into two general categories- proteins that generate mechanical forces and proteins that are subjected to mechanical forces. Proteins providing mechanical support to the structure of the cell, such as keratin, are subjected to mechanical force, whereas proteins involved in cell movement and transport of molecules across cell membranes, such as an ion pump, are examples of generating mechanical force.
5.6K
Structural Protein Function
29.9K
Structural proteins are a category of proteins responsible for functions ranging from cell shape and movement to providing support to major structures such as bones, cartilage, hair, and muscles. This group includes proteins such as collagen, actin, myosin, and keratin.
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to...
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to...
29.9K
The Equilibrium Binding Constant and Binding Strength
15.0K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.0K
Adult Stem Cells
33.8K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.8K
Factors Affecting Protein-Drug Binding: Protein-Related Factors
554
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
554
Ligand Binding and Linkage
5.6K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.6K

